Varelisa Scl-70 Antibodies
510(k) K944172
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK944172 | Date22 Dec 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5100
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
VARELISA SCL-70 ANTIBODIES is an immunology device that functions as an antinuclear antibody (enzyme-labeled) antigen and controls. It is designed for laboratory use in detecting specific antibodies related to Scl-70.
The device is supplied by Elias U.S.A., Inc. and is classified as Class 2 under product code LJM. It received FDA 510(k) clearance on December 22, 1994, with the K number K944172. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided in the data.
Other devices from Elias U.S.A., Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the VARELISA SCL-70 ANTIBODIES device used for?
The VARELISA SCL-70 ANTIBODIES is an immunology device designed for laboratory use in detecting specific antibodies related to Scl-70. It functions as an antinuclear antibody (enzyme-labeled) antigen and controls.
How is the VARELISA SCL-70 ANTIBODIES device supplied?
The device is supplied by Elias U.S.A., Inc. The data does not specify whether it is single-use or reusable, nor does it provide information about sterility or storage conditions.
What is the regulatory classification of the VARELISA SCL-70 ANTIBODIES device?
The device is classified as Class 2 under product code LJM and received FDA 510(k) clearance on December 22, 1994, with K number K944172. It is not specified as having FDA clearance or CE marking in the provided data.
What advisory committee reviewed the VARELISA SCL-70 ANTIBODIES device?
The device was reviewed by the Immunology advisory committee (IM), which is an administrative field indicating how the submission was filed, not a clinical indication of the device's intended use.